J&J wins FDA approval for TRUFILL system to treat chronic subdural hematoma via middle meningeal artery embolization.

FDA is removing barriers to real-world evidence in device applications, allowing the use of de-identified patient data from ...

Strategic realignments, innovation-driven investments, and other transformative events shaped the orthopedic market in 2025.

CMR Surgical said it is on track to begin commercialization of its Versius Plus surgical robotic platform in 2026 in the ...

Edwards pushes CMS to expand Medicare TAVR coverage as agency opens public comment period through January 2026 for decision.

These were among our most popular Trivia Tuesday articles this past year. Amanda Pedersen is a veteran journalist and ...

David Fischel, Stereotaxis CEO, talks about the market opportunity for the company’s surgical robotic solutions.

This week in Pedersen’s POV, MD+DI Senior Editor Amanda Pedersen explores the potential over-reliance on a medical device ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

The medtech job market faces major shifts in 2026 due to federal layoffs, AI adoption, and M&A activity. Versatile skills ...

Building FDA submissions like a solid house requires early collaboration, proactive planning, and a clear regulatory story.

Peijia's TaurusTrio TAV system wins NMPA approval, revolutionizing severe AR treatment with Jenavalve's locator technology.